Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

INTRODUCTION: We report the efficacy and safety of crizotinib treatment among Chinese patients with advanced-stage NSCLC. METHODS: We retrospectively analyzed patients with EML4-ALK positive advanced NSCLC who were treated with crizotinib from May 2012 to Aug 2013. Baseline clinical parameters, trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yabing, Xiao, Guangli, Qiu, Xibin, Ye, Sheng, Lin, Tongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264693/
https://www.ncbi.nlm.nih.gov/pubmed/25501361
http://dx.doi.org/10.1371/journal.pone.0114008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264693/
https://www.ncbi.nlm.nih.gov/pubmed/25501361
http://dx.doi.org/10.1371/journal.pone.0114008

Ejemplares similares